Clark Hill attorneys have represented companies in the pharmaceutical industry in a variety of capacities over the past two decades. Our attorneys' experience spans a multitude of areas which gives us the ability to provide prompt and able counsel on any matter that may arise. Michigan alone is home to over 500 companies with 31,000 employees and $4.8 billion in sales annually, and our firm has worked to protect the interests and assets of a number of these companies over the years.
[more]In matters ranging from litigation to legislation, our attorneys have effectively managed the interests of our pharmaceutical clients in the legal arena. Our litigators have defended against mass tort claims, our corporate finance attorneys have worked on private placements and public offerings to raise capital for pharmaceutical concerns, and our business attorneys have crafted licensing arrangements to outsource manufacturing and provide more efficient utilization of capital resources.
In terms of environmental issues, our environmental attorneys have supervised water remediation programs and advised concerning cGMP issues. Our intellectual property attorneys are qualified to protect research and development through obtaining patents, trademarks and protection of technology through confidentiality measures. Our government policy and practice attorneys work to establish laws which protect the intellectual property and work product of pharmaceutical companies.
Whether your needs involve development agreements, production or outsourcing arrangements, protection of intellectual property, NDA's or other regulatory issues, our attorneys have the capability and resources to effectively accommodate pharmaceutical enterprise.
Printable Version